Psoriasis associated with hepatitis C but not with hepatitis B

Dermatology

Volumn 220, Issue 3, 2010, Pages 218-222

  Cohen, Arnon D ^a,b   Weitzman, Dahlia ^c   Birkenfeld, Shlomo ^a   Dreiher, Jacob ^a,b  

^a CLALIT HEALTH SERVICES   (Israel)

^b Siaal Research Center for Family Medicine and Primary Care   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Comorbidity; Hepatitis B; Hepatitis C; Psoriasis

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; SCREENING; SMOKING; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; ISRAEL; MALE; MIDDLE AGED; PREVALENCE; PSORIASIS; YOUNG ADULT;

EID: 77951851823     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000286131     Document Type: Article

References (32)

1. Mehta S, Levey JM, Bonkovsky HL: Extrahepatic manifestations of infection with hepatitis C virus. Clin Liver Dis 2001; 5: 979-1008. (Pubitemid 33001016)
2. Bonkovsky HL, Mehta S: Hepatitis C: a review and update. J Am Acad Dermatol 2001; 44: 159-182. (Pubitemid 32172176)
3. Gottlieb AB, Chao C, Dann F: Psoriasis comorbidities. J Dermatol Treat 2008; 19: 5-21. (Pubitemid 351252710)
4. Griffiths CE, Iaccarino L, Naldi L, Olivieri I, Pipitone N, Salvarani C, et al: Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines. Clin Exp Rheumatol 2006; 24:S72-S78.
5. Ujiie H, Shimizu T, Shimizu H: Generalized pustular psoriasis and hepatitis C virus infection. Acta Virol 2004; 48: 63-64.
6. Yamamoto T, Nishioka K: Oral psoriasis in a patient with hepatitis C virus infection. Eur J Dermatol 2002; 12: 75-76. (Pubitemid 34131145)
7. Chouela E, Abeldano A, Panetta J, Ducard M, Neglia V, Sookoian S, et al: Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis. Int J Dermatol 1996; 35: 797-799. (Pubitemid 26391832)
8. Kanazawa K, Aikawa T, Tsuda F, Okamoto H: Hepatitis C virus infection in patients with psoriasis. Arch Dermatol 1996; 132: 1391-1392. (Pubitemid 26386637)
9. Yamamoto T, Katayama I, Nishioka K: Psoriasis and hepatitis C virus. Acta Derm Venereol 1995; 75: 482-483. (Pubitemid 26051892)
10. Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J: Association between psoriasis and the metabolic syndrome: a cross-sectional study. Dermatology 2008; 216: 152-155. (Pubitemid 351158580)
11. Rennert G, Peterburg Y: Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 2001; 3: 404-408. (Pubitemid 34176916)
12. Yurci A, Guven K, Torun E, Gursoy S, Baskol M, Akgun H, et al: Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C. Eur J Gastroenterol Hepatol 2007; 19: 811-815. (Pubitemid 47266713)
13. Scavo S, Gurrera A, Mazzaglia C, Magro G, Pulvirenti D, Gozzo E, et al: Verrucous psoriasis in a patient with chronic C hepatitis treated with interferon. Clin Drug Invest 2004; 24: 427-429. (Pubitemid 38951794)
14. Kartal ED, Colak H, Ozgunes I, Usluer G: Exacerbation of psoriasis due to peginterferon alpha-2b plus ribavirin treatment of chronic active hepatitis C. Chemotherapy 2005; 51: 167-169. (Pubitemid 40981076)
15. Seckin D, Durusoy C, Sahin S: Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection. Pediatr Dermatol 2004; 21: 577-579. (Pubitemid 39363180)
16. Erkek E, Karaduman A, Akcan Y, Sokmensuer C, Bukulmez G: Psoriasis associated with HCV and exacerbated by interferon alpha: complete clearance with acitretin during interferon alpha treatment for chronic active hepatitis. Dermatology 2000; 201: 179-181.
17. Downs AM, Dunnill MG: Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C. Clin Exp Dermatol 2000; 25: 351-352. (Pubitemid 30670597)
18. Cecchi R, Bartoli L: Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept). Dermatol Online J 2006; 12: 4. (Pubitemid 44954024)
19. De Simone C, Paradisi A, Capizzi R, Carbone A, Siciliano M, Amerio PL: Etanercept therapy in two patients with psoriasis and concomitant hepatitis C. J Am Acad Dermatol 2006; 54: 1102-1104. (Pubitemid 43732395)
20. Rokhsar C, Rabhan N, Cohen SR: Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection. J Am Acad Dermatol 2006; 54: 361-362. (Pubitemid 43144420)
21. Thaci D, Patzold S, Kaufmann R, Boehncke WH: Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two cases. Br J Dermatol 2005; 152: 1048-1050. (Pubitemid 40704952)
22. Favato G: High incidence of smoking habit in psoriatic patients. Am J Med 2008; 121:e17. (Pubitemid 351417847)
23. Huerta C, Rivero E, Rodriguez LA: Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559-1565. (Pubitemid 350277774)
24. Setty AR, Curhan G, Choi HK: Smoking and the risk of psoriasis in women: Nurses Health Study II. Am J Med 2007; 120: 953-959. (Pubitemid 350011082)
25. Fujita Y, Shibata A, Ogimoto I, Kuozawa Y, Nose T, Yoshimura T, et al: The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer 2006; 94: 737-739. (Pubitemid 43361907)
26. Mallat A, Hezode C, Lotersztajn S: Environmental factors as disease accelerators during chronic hepatitis C. J Hepatol 2008; 48: 657-665.
27. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, et al: Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 2001; 34: 121-125. (Pubitemid 32591491)
28. Dev A, Patel K, Conrad A, Blatt LM, McHutchison JG: Relationship of smoking and fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2006; 4: 797-801. (Pubitemid 43825810)
29. Hezode C, Lonjon I, Roudot-Thoraval F, Mavier JP, Pawlotsky JM, Zafrani ES, et al: Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 2003; 52: 126-129. (Pubitemid 36020778)
30. Wang CS, Wang ST, Chang TT, Yao WJ, Chou P: Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med 2002; 162: 811-815. (Pubitemid 34273305)
31. Tsochatzis E, Papatheodoridis GV, Manolakopoulos S, Tiniakos DG, Manesis EK, Archimandritis AJ: Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B. Scand J Gastroenterol 2009; 44: 752-759.
32. Israel Ministry of Health: HIV/AIDS in Israel, epidemiological periodic report 1981- 2007. http://www.health.gov.il/Download/ pages/ PeriodicReport2007final.pdf (accessed April 4, 2009).